{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03694",
      "entity_text" : "IC 50",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03688",
      "entity_text" : "COX-2 inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Recent research has also found that selective COX-2 inhibitors can enhance the sensitivity of tumor cells to many kinds of chemotherapeutic drugs, thus reducing the IC 50 of chemotherapeutic drugs by nearly 70% [XREF_BIBR].",
  "reading_complete" : "2020-08-02T14:41:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:40:10Z",
  "trigger" : "enhance",
  "evidence" : [ "COX-2 inhibitors can enhance the sensitivity of tumor cells to many kinds of chemotherapeutic drugs, thus reducing the IC 50" ],
  "pmc_id" : "3599060",
  "score" : 0
}